Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cinnamoyl-piperazine derivatives and their use as PAR-1 antagonists

Cinnamoyl-piperazine derivatives and their use as PAR-1 antagonists

US Patent 8217046 · Granted Jul 10, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sulfomaleimide-based linkers and corresponding conjugates2024
Antibody-drug-conjugate and its use for the treatment of cancer2024
Antibody-drug-conjugate and its use for the treatment of cancer2024
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer2023
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer2023
Antibody-drug-conjugate and its use for the treatment of cancer2022
Antibody-drug-conjugate and its use for the treatment of cancer2022
Antibody-drug-conjugate and its use for the treatment of cancer2022
Antibody-drug-conjugate and its use for the treatment of cancer2022
Antibody-drug-conjugate and its use for the treatment of cancer2021
Antibody-drug-conjugate and its use for the treatment of cancer2021
Composition for the treatment of IGF-1R expressing cancer2020